MicroVision Inc. (MVIS)
NASDAQ: MVIS
· Real-Time Price · USD
1.11
0.00 (0.00%)
At close: Sep 08, 2025, 3:59 PM
1.13
1.78%
After-hours: Sep 08, 2025, 07:47 PM EDT
MicroVision Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Contract Revenue Revenue | 40K | 85K | 51K | 125K | 51K | 53K | 1.09M | 1.05M | 68K | 192K |
| Contract Revenue Revenue Growth | -52.94% | +66.67% | -59.20% | +145.10% | -3.77% | -95.15% | +4.30% | +1439.71% | -64.58% | n/a |
| License and Royalty Revenue Revenue | 81K | 504K | 350K | 65K | 1.7M | 856K | n/a | n/a | 261K | 590K |
| License and Royalty Revenue Revenue Growth | -83.93% | +44.00% | +438.46% | -96.17% | +98.25% | n/a | n/a | n/a | -55.76% | n/a |
| Product Revenue Revenue | 34K | n/a | 3.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.44M | 6.68M | 5.92M | 6.6M | 5.98M | 7.28M | 7.94M | 8.74M | 9.69M | 8.74M | 6.38M | 5.52M | 6.26M | 5.88M | 6.65M | 5.01M | 8.36M | 2.25M | 1.38M | 1.49M | 1.28M | 1.77M | 1.28M | 1.7M | 2.46M | 2.7M | 2.57M | 2.25M | 2.09M | 2.61M | 3.19M | 2.06M | 2.33M | 2.58M | 2.27M | 2.23M | 2.17M | 2.07M | 2.14M | 1.87M | 1.95M | 1.92M |
| Selling, General, and Administrative Revenue Growth | -3.58% | +12.71% | -10.24% | +10.43% | -17.89% | -8.35% | -9.17% | -9.79% | +10.93% | +37.01% | +15.48% | -11.86% | +6.60% | -11.60% | +32.80% | -40.08% | +271.83% | +62.71% | -7.00% | +16.02% | -27.72% | +38.14% | -24.45% | -30.88% | -9.04% | +5.02% | +14.07% | +7.64% | -19.72% | -18.25% | +54.66% | -11.31% | -9.88% | +13.51% | +1.88% | +2.76% | +4.98% | -3.32% | +14.20% | -3.75% | +1.30% | n/a |
| Research and Development Revenue | 7.66M | 7.4M | 8.76M | 8.74M | 14.2M | 17.31M | 14.58M | 15.58M | 13.85M | 12.69M | 7.58M | 7.54M | 7.7M | 7.59M | 6.48M | 5.79M | 7.38M | 4.46M | 2.58M | 1.97M | 1.61M | 3.68M | 3.18M | 3.57M | 5.95M | 5.97M | 6.76M | 6.39M | 6.69M | 4.83M | 4.68M | 3.43M | 3.67M | 3.32M | 3.6M | 3.05M | 2.88M | 2.6M | 2.54M | 2.23M | 2.01M | 1.9M |
| Research and Development Revenue Growth | +3.44% | -15.53% | +0.32% | -38.50% | -17.95% | +18.73% | -6.44% | +12.51% | +9.13% | +67.33% | +0.66% | -2.14% | +1.41% | +17.14% | +11.93% | -21.49% | +65.31% | +73.08% | +30.73% | +22.71% | -56.37% | +15.93% | -10.91% | -40.02% | -0.47% | -11.66% | +5.87% | -4.56% | +38.59% | +3.18% | +36.53% | -6.67% | +10.67% | -7.96% | +18.08% | +6.04% | +10.86% | +2.24% | +13.85% | +10.94% | +5.95% | n/a |